Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: Evidence of urotensin II at the neuromuscular junction

Journal of Neurochemistry

Volumn 107, Issue 2, 2008, Pages 361-374

  Dubessy, Christophe ^a   Cartier, Dorthe ^a   Lectez, Benoît ^a   Bucharles, Christine ^a   Chartrel, Nicolas ^a   Montero Hadjadje, Maïté ^a   Bizet, Patrice ^a   Chatenet, David ^a   Tostivint, Hervé ^a   Scalbert, Elizabeth ^b   Leprince, Jérome ^a   Vaudry, Hubert ^a   Jégou, Sylvie ^a   Lihrmann, Isabelle ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Motoneuron; Motor end plate; UII receptor; Urotensin II; Urotensin II related peptide; Ventral medulla

Indexed keywords

MESSENGER RNA; SYNAPTOPHYSIN; UROTENSIN II;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BICEPS BRACHII MUSCLE; BRAIN STEM; CALCIUM MOBILIZATION; CHEMICAL ANALYSIS; COLON; CONTROLLED STUDY; FEMALE; GALLBLADDER; HEART; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL VESICLE; SKELETAL MUSCLE; SPINAL CORD MOTONEURON; STOMACH; TESTIS; THYMUS; TISSUE DISTRIBUTION; VAGINA; VESTIBULAR NUCLEUS;

ANIMALS; BRAIN; CALCIUM; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; FEMALE; MALE; MICE; NEUROMUSCULAR JUNCTION; PEPTIDE HORMONES; RADIOIMMUNOASSAY; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SYNAPTOPHYSIN; TYROSINE 3-MONOOXYGENASE; UROTENSINS;

EID: 53149138960     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05624.x     Document Type: Article

References (57)

1. Albertin G., Casale V., Ziolkowska A., Spinazzi R., Malendowicz L. K., Rossi G. P. Nussdorfer G. G. (2006) Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int. J. Mol. Med. 17, 1111 1115.
2. Ames R. S., Sarau H. M., Chambers J. K. et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401, 282 286.
3. Behm D. J., Harrison S. M., Ao Z. et al. (2003) Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice. Br. J. Pharmacol. 139, 464 472.
4. Behm D. J., Harrison S. M., Duddy G. et al. (2005) Targeted gene deletion of the murine prepro-urotensin-II gene is associated with a lean phenotype and increased cardiac mass and vascular hyper-reactivity. Circulation 112, II 187.
5. Brailoiu E., Brailoiu G. C., Miyamoto M. D. Dun N. J. (2003) The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br. J. Pharmacol. 138, 1580 1588.
6. Buffelli M., Pasino E. Cangiano A. (2001) In vivo acetylcholine receptor expression induced by calcitonin gene-related peptide in rat soleus muscle. Neuroscience 104, 561 567.
7. Chartrel N., Conlon J. M., Collin F., Braun B., Waugh D., Vallarino M., Lahrichi S. L., Rivier J. E. Vaudry H. (1996) Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J. Comp. Neurol. 364, 324 339.
8. Chartrel N., Leprince J., Dujardin C., Chatenet D., Tollemer H., Baroncini M., Balment R. J., Beauvillain J. C. Vaudry H. (2004) Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J. Neurochem. 91, 110 118.
9. Chatenet D., Dubessy C., Leprince J. et al. (2004) Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25, 1819 1830.
10. Chomczynski P. Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156 159.
11. Conlon J. M., O'Harte F., Smith D. D., Tonon M. C. Vaudry H. (1992) Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem. Biophys. Res. Commun. 188, 578 583.
12. Coulouarn Y., Lihrmann I., Jégou S., Anouar Y., Tostivint H., Beauvillain J. C., Conlon J. M., Bern H. A. Vaudry H. (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl Acad. Sci. USA 95, 15803 15808.
13. Coulouarn Y., Jégou S., Tostivint H., Vaudry H. Lihrmann I. (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett. 457, 28 32.
14. Coulouarn Y., Fernex C., Jégou S., Henderson C. E., Vaudry H. Lihrmann I. (2001) Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech. Dev. 101, 187 190.
15. Do-Rego J. C., Chatenet D., Orta M. H., Naudin B., Le Cudennec C., Leprince J., Scalbert E., Vaudry H. Costentin J. (2005) Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology (Berl.) 183, 103 117.
16. Douglas S. A., Tayara L., Ohlstein E. H., Halawa N. Giaid A. (2002) Congestive heart failure and expression of myocardial urotensin II. Lancet 359, 1990 1997.
17. Douglas S. A., Dhanak D. Johns D. G. (2004a) From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol. Sci. 25, 76 85.
18. Douglas S. A., Naselsky D., Ao Z., Disa J., Herold C. L., Lynch F. Aiyar N. V. (2004b) Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br. J. Pharmacol. 142, 921 932.
19. Dun S. L., Brailoiu G. C., Yang J., Chang J. K. Dun N. J. (2001) Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci. Lett. 305, 9 12.
20. Egginger J. G. Calas A. (2005) A novel hypothalamic neuroendocrine peptide: URP (urotensin-II-related peptide)? C. R. Biol. 328, 724 731.
21. Egginger J. G., Camus A. Calas A. (2006) Urotensin-II expression in the mouse spinal cord. J. Chem. Neuroanat. 31, 146 154.
22. Elshourbagy N. A., Douglas S. A., Shabon U. et al. (2002) Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br. J. Pharmacol. 136, 9 22.
23. Eritja R., Ziehler-Martin J. P., Walker P. A., Lee T. D., Legesse K., Albericio F. Kaplan B. E. (1987) On the use of s-t-butylsulphenyl group for protection of cysteine in solid-phase peptide synthesis using fmoc-amino acids. Tetrahedron 43, 2675 2680.
24. Fernandez H. L., Ross G. S. Nadelhaft I. (1999) Neurogenic calcitonin gene-related peptide: a neurotrophic factor in the maintenance of acetylcholinesterase molecular forms in adult skeletal muscles. Brain Res. 844, 83 97.
25. Filipeanu C. M., Brailoiu E., Le Dun S. Dun N. J. (2002) Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J. Neurochem. 83, 879 884.
26. Flohr S., Kurz M., Kostenis E., Brkovich A., Fournier A. Klabunde T. (2002) Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 45, 1799 1805.
27. Gartlon J., Parker F., Harrison D. C. et al. (2001) Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl.) 155, 426 433.
28. Heller J., Schepke M., Neef M., Woitas R., Rabe C. Sauerbruch T. (2002) Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J. Hepatol. 37, 767 772.
29. Hodges-Savola C. A. Fernandez H. L. (1995) A role for calcitonin gene-related peptide in the regulation of rat skeletal muscle G4 acetylcholinesterase. Neurosci. Lett. 190, 117 120.
30. Hood S. G., Watson A. M. May C. N. (2005) Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade. Peptides 26, 1248 1256.
31. Huitron-Resendiz S., Kristensen M. P., Sanchez-Alavez M. et al. (2005) Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J. Neurosci. 25, 5465 5474.
32. Ichikawa T., Lederis K. Kobayashi H. (1984) Primary structures of multiple forms of urotensin II in the urophysis of the carp, Cyprinus carpio. Gen. Comp. Endocrinol. 55, 133 141.
33. Jégou S., Cartier D., Dubessy C., Gonzalez B. J., Chatenet D., Tostivint H., Scalbert E., LePrince J., Vaudry H. Lihrmann I. (2006) Localization of the urotensin II receptor in the rat central nervous system. J. Comp. Neurol. 495, 21 36.
34. Jinnai K., Chihara K., Kanda F., Tada K. Fujita T. (1989) Calcitonin gene-related peptide enhances spontaneous acetylcholine release from the rat motor nerve terminal. Neurosci. Lett. 103, 64 68.
35. Labarrère P., Chatenet D., Leprince J. et al. (2003) Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J. Enzyme Inhib. Med. Chem. 18, 77 88.
36. Lin Y., Tsuchihashi T., Matsumura K., Abe I. Iida M. (2003) Central cardiovascular action of urotensin II in conscious rats. J. Hypertens. 21, 159 165.
37. Liu Q., Pong S. S., Zeng Z. et al. (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem. Biophys. Res. Commun. 266, 174 178.
38. Lu J. T., Son Y. J., Lee J. et al. (1999) Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol. Cell. Neurosci. 14, 99 120.
39. Lu Y., Zou C. J., Huang D. W. Tang C. S. (2002) Cardiovascular effects of urotensin II in different brain areas. Peptides 23, 1631 1635.
40. Maguire J. J., Kuc R. E. Davenport A. P. (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131, 441 446.
41. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N. Hirata Y. (2001) Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J. Hypertens. 19, 2185 2190.
42. Matteoli M., Balbi S., Sala C., Chini B., Cimino M., Vitadello M. Fumagalli G. (1990) Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction. J. Mol. Neurosci. 2, 175 184.
43. Mori M., Sugo T., Abe M. et al. (1999) Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem. Biophys. Res. Commun. 265, 123 129.
44. New H. V. Mudge A. W. (1986) Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. Nature 323, 809 811.
45. Ono T., Kawaguchi Y., Kudo M. et al. (2008) Urotensin II evokes neurotransmitter release from rat cerebrocortical slices. Neurosci. Lett. 440, 275 279.
46. Paxinos G. Franklin K. (2004) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
47. Pearson D., Shively J. E., Clark B. R., Geschwind I. I., II., Barkley M., Nishioka R. S. Bern H. A. (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl Acad. Sci. USA 77, 5021 5024.
48. Pelletier G., Lihrmann I. Vaudry H. (2002) Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 115, 525 532.
49. Pelletier G., Lihrmann I., Dubessy C., Luu-The V., Vaudry H. Labrie F. (2005) Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132, 689 696.
50. Rouille Y., Duguay S. J., Lund K., Furuta M., Gong Q., Lipkind G., Oliva A. A. Jr., Chan S. J. Steiner D. F. (1995) Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuroendocrinol. 16, 322 361.
51. Seidah N. G., Day R., Marcinkiewicz M. Chretien M. (1998) Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. NY Acad. Sci. 839, 9 24.
52. Silvestre R. A., Egido E. M., Hernandez R., Leprince J., Chatenet D., Tollemer H., Chartrel N., Vaudry H. Marco J. (2004) Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas. Eur. J. Endocrinol. 151, 803 809.
53. Sugo T., Murakami Y., Shimomura Y. et al. (2003) Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310, 860 868.
54. Tostivint H., Joly L., Lihrmann I., Parmentier C., Lebon A., Morisson M., Calas A., Ekker M. Vaudry H. (2006) Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc. Natl Acad. Sci. USA 103, 2237 2242.
55. Totsune K., Takahashi K., Arihara Z., Sone M., Satoh F., Ito S., Kimura Y., Sasano H. Murakami O. (2001) Role of urotensin II in patients on dialysis. Lancet 358, 810 811.
56. Totsune K., Takahashi K., Arihara Z., Sone M., Ito S. Murakami O. (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin. Sci. 104, 1 5.
57. Watson A. M., Lambert G. W., Smith K. J. May C. N. (2003) Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42, 373 379.